JP Patent

JP2006514102A — ２−オキソ−エタンスルホンアミド誘導体

Assigned to AstraZeneca AB · Expires 2006-04-27 · 20y expired

What this patent protects

１１βＨＳＤ１の阻害に使用する式（Ｉ）の化合物（式中、可変基は本明細書に記載のとおりである）が記載される。【化１】

USPTO Abstract

１１βＨＳＤ１の阻害に使用する式（Ｉ）の化合物（式中、可変基は本明細書に記載のとおりである）が記載される。【化１】

Drugs covered by this patent

Tradjenta (LINAGLIPTIN) · Boehringer Ingelheim

Patent Metadata

Patent number: JP2006514102A
Jurisdiction: JP
Classification: —
Expires: 2006-04-27
Drug substance claim: No
Drug product claim: No
Assignee: AstraZeneca AB
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.